Latest Dengue Fever News

Page 2 of 2

Island Pharmaceuticals Completes Phase 2b Enrollment in Dengue Trial

Island Pharmaceuticals has enrolled all subjects in the Phase 2b arm of its ISLA-101 dengue fever clinical trial, advancing its antiviral drug development with key results expected in 2025.

Victor Sage

22 Jan 2025

Top